CEREBRAL blood vessels receive a rich complement of both adrenergic and cholinergic nerve fibers (Edvinsson and MacKenzie, 1977) ; however, despite intense investigation, the functional significance of these fibers remains controversial (Heistad and Marcus, 1978) . Several lines of evidence now suggest that cerebral vessels may be innervated also by a third type of nerve fiber containing neither adrenergic nor cholinergic neurotransmitter substances. First, transmural electric stimulation of isolated
SUMMARY A potential role for cerebrovascular nerves containing vasoactive intestinal polypeptide (VIP) -was examined in 24 anesthetized, ventilated dogs. Cerebral blood flow (CBF) was measured by
either the cerebral venous outflow or microsphere method. Plasma VIP concentration was measured by radioimmunoassay. Hypercapnia (5% and 10% CO 2 ) and hypoxia (7% O 2 ) produced significant increases in cerebral venous outflow, but had no affect on arterial or cerebral venous VIP concentrations. Measurements of VIP in cerebrospinal fluid (CSF) made during 5% and 8% CO 2 breathing also were not different from control values. VIP produced large dose-dependent increases in common carotid artery and temporalis muscle blood flow when injected or infused intraarterially; however, VIP had no effect on total or regional cerebral blood flow (rCBF) within the brain when administered in a similar manner. Unilateral perfusion of the cerebral ventricles with VIP produced significant increases (range: 11-80%) in rCBF. These data are consistent with the possibility that local release of VIP from peri vascular nerve endings could affect CBF. The unresponsiveness of canine cerebral vessels to blood-borne VIP may be due to the blood-brain barrier, since VIP dilates cerebral vessels when the barrier is bypassed by intraventricular infusion. These studies do not support the hypothesis that CBF changes induced during hypercapnia or hypoxia are mediated by VIP. Circ Res 48: [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] 1981 CEREBRAL blood vessels receive a rich complement of both adrenergic and cholinergic nerve fibers (Edvinsson and MacKenzie, 1977) ; however, despite intense investigation, the functional significance of these fibers remains controversial (Heistad and Marcus, 1978) . Several lines of evidence now suggest that cerebral vessels may be innervated also by a third type of nerve fiber containing neither adrenergic nor cholinergic neurotransmitter substances. First, transmural electric stimulation of isolated cerebral vessels evokes relaxation of vascular smooth muscle that is not inhibited by a-adrenergic, /8-adrenergic, cholinergic, histaminergic, or serotonergic receptor site antagonists (Lee et al., 1978) . However, Lee et al. (1976) also showed that vasoconstriction was not inhibited by a antagonists, suggesting that either the a receptor is unusual or that another neurotransmitter may be involved. Second, morphological studies have shown that many cerebral vessels contain fibers similar to type-P peptidergic nerve fibers found in the gastrointestinal tract and that some of these fibers contain vasoactive intestinal polypeptide (VIP) (Larsson et al., 1976a) . VIP, originally isolated from porcine duodenum (Said and Mutt, 1970a) , is a 28 amino acid residue peptide, structurally related to secretin and glucagon (Said and Mutt, 1972) . In the central nervous system, VIP occurs in high concentrations in corti-cal, hypothalamic, and limbic areas, with lower concentrations in the cerebellum, brainstem, and thalamic areas (Besson et al., 1979; Said and Rosenberg, 1976; Samson et al., 1979) . Its presence in bipolar cortical neurons localized to molecular layers II-IV (Fuxe et al., 1977) and the fact that it can be released from synaptosomes by calcium dependent potassium depolarization (Emson et al., 1978; Giachetti et al., 1977) suggest that VIP may perform a neurotransmitter function. This peptide is a potent vasodilator in the peripheral gastrointestinal and coronary circulations (Said and Mutt, 1970b) and can relax cerebral vessels (Larsson et al., 1976b) as well as a variety of nonvascular muscles (Said, 1974) .
The functional significance of the VIP-containing cerebrovascular nerves is unknown. The purpose of these studies was to test the hypothesis that the cerebral vasodilation in response to hypercapnia or hypoxia is mediated through the VIP-containing nerve system. Although there is no direct evidence in the literature to suggest that VIP might be released by hypoxia, preliminary data suggest that VIP is released from the gut by hypercapnia (H. Sakio and S.I. Said, personal communication) . It also has been demonstrated that several physiological stimuli, such as mechanical stimulation of portions of the gastrointestinal tract and sympathetic nerve stimulation, result in alteration of VIP in portal venous plasma and that this release is accompanied by changes in portal vein blood flow (Fahrenkrug et al., 1978a (Fahrenkrug et al., , 1978b . In addition, we determined whether cerebral blood flow could be influenced by either intra-arterial or intra-cerebroventricular administration of VIP.
Methods

General Procedures
Experiments were done on 24 adult mongrel dogs of either sex (18-25 kg) anesthetized with sodium pentobarbital (30 mg/kg, iv). Supplemental doses of anesthetic were given so that corneal and pedal withdrawal reflexes were depressed completely. Heparin (500 U/kg, iv) was used as the anticoagulant, with additional doses given every 90 minutes. Dogs were paralyzed with gallamine triethiodide (Flaxedil, 40 mg) and ventilated with a positive pressure respirator (Harvard Apparatus Co., model 607) connected to a tracheal cannula. Tidal volume and ventilatory rate were adjusted to maintain arterial carbon dioxide tension within the range of 32-36 mm Hg. Dissection to expose the femoral artery and vein, trachea, common carotid arteries, omocervical artery, and cranium was done with an electric cautery. Arterial blood pressure was measured via a catheter placed in the omocervical artery. To prevent cooling, the dogs were covered with a plastic sheet and all surgical areas, where possible, were sutured. Rectal temperature was maintained around 38° C throughout the experiment with a thermostatically controlled heating pad or heat lamp. All pressures were measured with Statham P-23Db transducers and all data were recorded on an Electronics for Medicine recorder.
Measurement of Blood Flows
Cerebral Venous Outflow Technique
The technique used to measure cerebral venous outflow has been described by Rapela and Green (1964) . The confluence of the cerebral sinuses was cannulated, and the lateral sinuses and occipital emmissary veins were occluded with bone wax to prevent communications between the intracranial and extracranial venous circulations. Blood passed from the confluence of the sinuses through a previously calibrated electromagnetic flow probe, and returned to the dog via the femoral vein (Fig. 1) . Approximately 50 to 70% of the mass of the brain is drained at the confluence of the sagittal and straight sinuses with this technique. Cerebral venous outflow pressure was measured at the conflu- VOL. 48, No. 1, JANUARY 1981 ence of the sinuses. This pressure measures the resistance to the flow of blood induced by the flow transducer since the outflow was open to atmospheric pressure. The tip of the outflow cannula was set at the level of the right atrium and all pressures were referred to this common zero reference plane. Brain perfusion pressure was estimated as mean arterial pressure minus cerebral venous outflow pressure. Intracranial vascular resistance was calculated by dividing brain perfusion pressure by cerebral venous outflow.
The verification procedures for this technique of measuring cerebral blood flow have been previously presented (Traystman and Rapela, 1975; Traystman et al., 1978 ) and thus will not be described here. However, it should be pointed out that this preparation exhibits good autoregulation (Rapela and Green, 1964) and shows excellent vasodilator responses to hypoxia (Pitt et al., 1979; Traystman et al., 1978) and hypercapnia (Traystman and Rapela, 1975) . In the present experiments, each animal was exposed to carbon dioxide (10% CO 2 in inspired air) to evaluate the responsiveness of the cerebral vessels. Any preparation that did not respond to CO 2 with cerebral vasodilation (at least a doubling in flow within 10 minutes of CO 2 onset) was discarded.
Extracranial blood flow was estimated in all animals by means of a noncannulating electromagnetic flow probe placed around the left, right, or both common carotid arteries (Fig. 1) . Systemic arterial pressure was taken as extracranial perfusion pressure and used to calculate extracranial vascular resistance.
Radiolabeled Microsphere Technique
Regional cerebral blood flow (rCBF) was measured with labeled microspheres (15 ± 3 ^m in diameter) using the reference sample method (Marcus et al., 1976) . Microspheres were injected into the left ventricle via a catheter passed through a femoral artery. The reference blood sample was withdrawn from the contralateral femoral artery using a Harvard withdrawal pump. Prior to each microsphere injection, the vial containing spheres was hand shaken vigorously and then agitated in an ultrasonic mixer for 20 minutes. Microscopic observations of the spheres made in our laboratory have shown this procedure to be sufficient to ensure an even dispersion of spheres. Approximately 3-4 X 10 6 spheres were injected for each measurement of flow [ 141 Ce, ^Sr, 46 Sc (3M Co.), and n3 Sn (New England Nuclear)]. This quantity was chosen to allow at least 400 spheres to be delivered to the smallest regional area from which tissue samples were collected. The microspheres were injected into the left ventricle over a 60-second period. The reference blood sample was collected from the femoral artery at 4.94 ml/min beginning 30 seconds before the injection and lasting until 30 ml of blood had been withdrawn. The spheres did not alter blood pressures, cardiac output, blood gases, or pH.
At the conclusion of the experiment the animal was killed with KC1 and the brain and cervical spinal cord segment were removed and placed into 10% buffered formalin for 3 to 10 days. The left and right hemispheres then were cut into discrete areas: right and left spinal cord, medulla, cerebellum, pons, midbrain, diencephalon, hippocampus, caudate nucleus, occipital lobe, temporal lobe, parietal lobe, frontal lobe, and olfactory lobe. Cortical gray matter samples were obtained by scraping the surface of each of the selected lobes. A weighted blood flow value for each lobe was obtained by pooling the counts for the remaining lobe tissue (white matter plus remaining gray matter) and the counts from the appropriate gray tissue sample. Samples of right and left temporalis muscle were taken as an estimate of extracranial blood flow.
After the tissue samples had been weighed, they were placed in 15-ml Poly Q vials and counted in a Packard Multichannel analyzer (model 9042) with a 3" through-hole Nal crystal. Reference blood samples were divided into aliquots so that counting geometry was similar to that of the tissue samples. Sc isotopes were 120-170, 350-430, 470-580, and 800-1300 keV, respectively. Backscatter from higher energy isotopes into windows of lower energy emission was substracted for a corrected count value using differential spectroscopy by the method of Rudolph and Heyman (1967) .
Cerebral blood flow was calculated from the equation: CBF = C B X (RBF/C R ) X 100, where CBF = cerebral blood flow in ml/min per 100 g, CB = counts per gram of brain, RBF = reference blood flow (rate of withdrawal blood sample) and CR = total counts in the reference arterial blood sample. Temporalis muscle blood flow was calculated similarly.
Administration of Hypercapnia and Hypoxia; Blood Gas and VIP Analysis
The effects of hypercapnia and hypoxia on cerebral blood flow and endogenous VIP were studied in two groups of five dogs. In one group, animals were ventilated with mixtures of 5% and 10% CO2 in air, and 7% O 2 in nitrogen, administered in random order sequence. Each administration of the experimental gas was separated by a control period of ventilation with room air. CBF was recorded continuously via the venous outflow technique. In the second group, animals were ventilated with 5% and 8% CO2 in air and rCBF was measured, using radiolabeled microspheres. Dogs were maintained at a given level of hypercapnia or hypoxia for 20-30 minutes to allow equilibration of ventilatory and blood gases before final gas samples were taken, and to allow time for hemodynamic responses to occur and to be maintained. Arterial and cerebral venous blood samples, for blood gas and VIP analysis, were taken from the omocervical artery and cerebral venous outflow cannulae, respectively. The experimental protocol was such that each dog acted as its own control for different levels of hypercapnia and hypoxia. Oxygen tension (Po 2 ), carbon dioxide tension (Pco 2 ), and pH were measured at 37°C immediately after the samples were obtained using radiometer electrodes and analyzer (BMS 2). The electrodes were calibrated with air (20.08% O 2 ) and mixtures of oxygen in nitrogen (around 8%) and carbon dioxide in air (around 5% and 10% CO2), analyzed to a precision of 0.01%. The pH electrode was calibrated with standard phosphate buffers (6.841; 7.383). Oxygen saturation and hemoglobin also were measured immediately after samples were taken with an IL CO-oximeter (model 182). Electrodes were calibrated before and after each set of samples were taken. During hypoxia, end-expiratory CO 2 was maintained constant throughout the exposure period.
Arterial and cerebral venous blood samples also were obtained for VIP analysis. Blood (3-4 ml) was drawn into an evacuated glass tube containing 10.5 mg EDTA and 1000 U aprotinin (Transylol). These samples immediately were centrifuged to separate cells and plasma, and the decanted plasma was frozen. Cerebral spinal fluid (CSF) samples (1 ml) were collected from a spinal needle placed in the cisterna magna, immediately transferred to a glass tube containing Aprotinin, and frozen. An equivalent volume of mock CSF replaced the volume of CSF taken for VIP analysis. Plasma and CSF samples were analyzed for VIP content using a blind procedure; i.e., samples were coded in one laboratory, shipped frozen to another laboratory (S.I. Said) for VIP analysis, and decoded in the original laboratory upon return of the results. VIP content was determined in duplicate using a radiommunoassay that has been described elsewhere (Said, 1979) . It should be pointed out that the antibodies used in this assay are not cross-reactive with the peptides: secretin, glucagon, cholecystokinin-pancreozymin, bradykinin, substance-P, somatostatin, porcine pancreatic polypeptide, neurotensin, a-endorphin, leu-enkephalin, met-enkephalin, angiotensin II, oxytocin, vasopression, /Mipotropin, LHRH and TSH. This immunoassay can detect VIP in concentrations as low as 10 pg/ml with 95% confidence.
Intra-arterial Injections and Infusions of VIP
The effect of blood-borne VIP on CBF was studied in two groups of three dogs. In the first group, VIP (0.1, 1.0, 10.0, and 20.0 ng) was administered as a bolus injection into each common carotid artery. CBF was recorded continuously via the venous outflow technique. In the second group, VIP (10 jug/ml) was infused bilaterally into both common carotid arteries at a rate of 1.0 ml/min per carotid artery. A single dose of 10.0 /xg/min per carotid was chosen because of the large changes it induced in carotid blood flow. We measured rCBF with radiolabeled microspheres. Four microsphere control measurements were made: the first and third injections represented control measurements and were made during the infusion of saline at an equivalent volume rate as the VIP infusion; the second and fourth injections were made during VIP infusions. Microspheres were not injected until carotid artery blood flow had been altered and was stable for at least 20-30 seconds. Administration of all drugs was accomplished via a set of indwelling needle catheters placed in the carotid arteries. All drugs were dissolved in saline and for the bolus injections, although the doses of the drugs administered differed, the volume delivered always remained the same. Bolus injections of saline (same volume as VIP bolus injections) acted as the control injection for each dose of VIP and were administered prior to each dose of VIP.
Intra-CSF Infusion of VIP
The effect of intraventricular infusion of VIP was studied in five dogs. A 20-gauge spinal needle was placed in the cisterna magna and attached to a mock CSF-filled polyvinyl chloride tube (Fig. 1) . The CSF outflow cannula tip was positioned 1-2 cm above the level of the cisterna and CSF was allowed to drain into a collection cylinder. A #16 gauge blunt needle was positioned in the left cerebral ventricle through a small hole drilled in the skull. Mock CSF (Levasseur et al., 1975) equilibrated with a rr" ture of 7% CO 2 in air was perfused through the ventriculo-cisternal system at 0.5 ml/ min with a roller pump (Gilson minipuls #2). Polyethylene tubing was used in the perfusion system to minimize loss of CO 2 from the perfusate. CSF inflow pressure, referenced to a plane passing through the lateral ventricle, was recorded in all animals. Preparations in which inflow pressure rose above 20 mm Hg, or in which the outflow CSF was blood tinged, were discarded. Control rCBF measurements were made following a 30-minute equilibration period during which mock CSF was perfused through the system. The control mock CSF solution was then exchanged for one containing VIP, lO^g/ml. We again measured rCBF at 30 and 60 minutes after the beginning of the CSF-VIP infusion. In three additional animals, the ventricular system was perfused with mock CSF containing no VIP for a period of 120 minutes. These preparations served as a group of time control animals.
Statistical Analysis
In all studies involving multiple treatment comparisons (with the exception of the intraventricular VIP perfusion studies), a random complete block analysis of variance (Meyers, 1966) was used as the experimental design. Individual animal variability was isolated as a blocking factor and significant differences between the treatments were identified using Duncan's multiple range test. Regression lines relating cerebral venous to arterial VIP concentra- VOL. 48, No. 1, JANUARY 1981 tions under differing experimental conditions were evaluated for equality by standard regression analysis techniques (Snedecor and Cochran, 1978) . In the intraventricular perfusion experiments the differences between control and experimental treatments were evaluated against Dunnetts d statistic. The level of statistical significance was set at 0.05 in all evaluations. Figure 2 shows the effects of two levels of hypercapnia (5% and 10% CO 2 ) and one level of hypoxia (7% O 2 ) on CBF and arterial and cerebral venous plasma VIP concentrations. During room air breathing (control) a wide range of variability was encountered in both the arterial and cerebral venous VIP concentrations. The range for arterial and cerebral venous VIP was 10 to 278 pg/ml and 28 to 270 pg/ml with mean values of 123.4 ± 11.9 (SE) and 129.5 ± 12.2 (SE) pg/ml, respectively. However, both arterial and cerebral venous VIP concentrations remained stable throughout the experiment in any given preparation; i.e., the four control VIP levels (room air) did not change over the 90-minute duration of the experiment, and neither hypercapnia nor hypoxia altered these VIP levels. CBF (cerebral venous outflow) increased markedly to 168, 256, and 296% of control with 5% and 10% C0 2 and 7% 0 2 breathing, respectively. Despite the large changes in CBF with these different gas mixtures, arterial and cerebral venous VIP concentrations remained unchanged from control values. CBF and cerebral oxygen consumption (CMR0 2 ), mean arterial blood pressure (Pa) and blood gas values for this group of dogs are given in Table 1 . Figure 3 plots all measured cerebral venous VIP concentrations against the corresponding arterial VIP concentration during control, hypercapnic, and hypoxic conditions. The arterial-cerebral venous pairs were scattered equally around the line of identity throughout the entire range of values (i.e., regression line for 5% and 10% C0 2 and 7% 0 2 were not different from either the line of identity or each other). This indicates that the release of VIP from the brain tissue into the venous effluent was insignificant in control conditions and was not altered by hypercapnia or hypoxia.
Results
Cerebral Blood Flow Responses and Endogenous VIP Release in Hypercapnia and Hypoxia
The effects of two levels of hypercapnia (5% and 8% CO 2 ) on CBF and arterial and CSF VIP concentrations is shown in Figure 4 . Total CBF (measured with microspheres) increased to 160% and 344% of control with 5% and 8% CO 2 , respectively; however, both arterial and CSF VIP concentrations remained at control values (room air breathing). In this group of dogs, the CO 2 breathing period was 30 minutes, allowing any VIP that may have been released from brain tissue to equilibrate with the CSF. Figure 5 shows the effects of VIP (0.1, 1.0, 10.0, 20.0 /xg) injected into each common carotid artery on cerebral and cephalic blood flow. Each response to a given dose of VIP was paired to its own control (saline) response. Cerebral venous outflow (CBF) remained unchanged with each increasing dose of VIP, whereas mean arterial blood pressure decreased by 10% and 13% with 10.0 and 20.0 jug VIP, respectively. Thus, cerebrovascular resistance decreased at these high VIP dose levels, and we interpret these changes to be the result of cerebral autoregulation. Common carotid blood flow, however, increased markedly to 118, 210, and 245% of control with 1.0, 10.0, and 20.0 jug VIP.
The Effect of Arterial VIP on Cerebral and Cephalic Blood Flow
Since the cerebral venous outflow technique measures only mean cerebral blood flow, we wanted to examine the possibility that VIP might alter the regional distribution of blood flow within deep brain structures. Therefore we infused VIP (10.0 jug/VIP per min) into both common carotid arteries and Each value represents the mean + SE of five dogs. Pa = mean arterial blood pressure, CBF = cerebral blood flow, CMRO 2 = * Denotes significant difference from pre-and post-control level at the P < 0.05 level.
cerebral O 2 consumption.
measured CBF with the microsphere technique. This VIP infusion rate resulted in marked increases in common carotid blood flow to 326% of control. Saline infusion at the same rate over the same time period served to establish the control response. The microspheres were injected after common carotid blood flow had increased and remained stable for at least 30 seconds. The effects of VIP infusion on rCBF are shown in Figure 6 . VIP had no effect on rCBF in any brain region examined. Of note is the finding that blood flow to the hypophysis increased to 217% of control. VIP infused twice in each of two animals resulted in an increase in pituitary blood flow (to 196 and 316% of control in one animal and 178 and 180% of control in the other) when compared to a saline infusion preceding control. However, because hypophyseal blood flow was measured in only two animals, the level of significance could not be determined. On the other hand, extracranial blood flow (temporalis muscle) increased markedly to 680% of control with infusion of VIP. Common carotid blood flow increased with VIP infusions by a lesser amount than did temporalis blood flow, as expected, since the common carotid flow measurement includes flow delivered to bone, skin, and other cephalic tissues, as well as that going to the brain and facial muscles. Table 2 shows that intraventricular CSF VIP infusion (10 jtig/ml) for 30 minutes resulted in significant increases in blood flow (microsphere technique) to the areas of the occipital gray matter, caudate nucleus, medulla, spinal cord, and cerebellum. It should be noted also that after 30-minutes intra-CSF VIP perfusion, every brain area measured showed a tendency toward increased flow (range: 11% to 88% change from control) and that total brain blood flow increased by 41%. Significant changes occurred in those regions directly along the path of the perfusate, i.e., left caudate nucleus, medulla, cerebellum, cervical spinal cord and occipital gray matter. Following 60-minutes perfusion with VIP, each brain area still showed an increase in blood flow from control, but the 60-minute flow value was less than that observed at 30 minutes. The elevated blood flows at 30 and 60 minutes were not produced as a result of the ventriculo-cisternal perfusion technique, since in a group of three dogs in which the perfusion was performed identically, except that VIP was not added to the perfusate, there was no change in rCBF. Arterial blood gases, pH, and mean arterial blood pressure were unaltered by intra-CSF VIP perfusion. Intra-CSF VIP perfusion had no effect on extracranial blood flow as illustrated by the constancy in temporalis muscle flow. Temporalis flow was unusually high in these experiments, but we have observed this previously, especially when the muscle was traumatized during exposure of the cranium. Note that temporalis flow decreased at 30 and 60 minutes; i.e. during recovery from trauma, and that these values were not different from the control measurements. Temporalis muscle blood flow shown in Table 2 is higher than that shown in Figure 6 . This can be attributed to the fact that for the experiments presented in Figure 6 , no surgery to the head area was required.
The Effect of Intraventricular VIP Perfusion on Cerebral Blood Flow
That blood flow is somewhat lower through grey matter than through the lobe from which grey matter samples were taken (Table 2) is curious. However, these flow values were significantly different for the frontal lobe only, and we attribute this finding either to contamination of the grey tissue sample, or to the effect of differing counting geometries.
Discussion
The Effect of Intra-arterial VIP on Cerebral and Cephalic Blood Flow Cerebral blood vessels are less sensitive to a variety of systemically administered vasoactive 100 gm 50.2 ± 13.8* 47.6 ± 11.6
56.4 ± 11.1* 44.8 ± 11.0 37.1 ± 7.2* 40.5 ± 7.5 46.1 ± 8.7 31.8 ± 6.2 43.1 ± 9.0* 38.2 ± 5.7* 49.7 ± 8.2* 27.2 + 4.9 31.2 ± 8.6 60min 7.409 ± 0.010 30.9 ± 2.3 87.2 ± 3.3 152 ± 2 31.3 ± 7.5
22.9 ± 8.3 28.5 ± 7.4
27.7 ± 8.5 28.6 ± 7.3 27.7 ± 8.5 26.9 ± 6.7
37.4 ± 12.5 37.0 ± 11.1 52.0 ± 12.8* 43.6 ± 12.1 30.3 ± 6.4 35.6 ± 9.9 38.9 ± 10.4 29.1 ± 5.9 40.6 ± 9.2* 32.1 ± 4.3* 41.2 ± 7.4 25.5 ± 6.1 17.8 ± 4.0
Each value represents the mean ± SE of five dogs. Pa = mean arterial blood pressure. * P < 0.05 from time 0.
substances than are the cephalic vessels (O'Neill and Traystman, 1977) . Multiple factors contribute to this phenomenon. The blood-brain barrier prevents intravascular proteins, ions, and many watersoluble nonelectrolytes from entering the brain parenchyma (Ohno et al., 1978) . Reese and Karnovsky (1967) showed that it is the tight junctions cementing adjacent endothelial cell membranes that are responsible for preventing the passage of exogenous peroxidases. On the other hand, muscle capillaries lack tight junctions (Karnovsky, 1967) and are more permeable (Ohno et al., 1978) . Besides the physical restrictions to diffusion imposed by the blood-brain barrier, the endothelial cell lining of cerebral vessels may contain inactivating enzymes that can further impede the passage of intact substances (Bertler et al., 1966) . Recently, both in vitro preparations (Bevan, 1979 ) and in vivo studies in which the bloodbrain barrier was disrupted osmotically by hypertonic urea (MacKenzie et al., 1976) have strengthened the idea that cerebral vessels have a lower intrinsic sensitivity to vasoconstrictor stimuli, such as norepinephrine, than do peripheral vessels. The present study clearly shows that intra-and extracranial blood vessels respond differently to arterial administration of VIP. Intra-arterial VIP produced large dose-dependent increases in common carotid and temporalis muscle blood flow. Administration of VIP in doses of 10 jug or more also produced small decreases in arterial blood pressure. Despite the reduction in pressure, the cephalic response was unequivocal, since carotid vascular resistance was reduced far more than arterial blood pressure. The lack of effect of blood-borne VIP on cerebral blood flow also is clear. Throughout both the injection and infusion studies, total and regional CBF remained remarkably constant and independent of the VIP dose. Although cerebrovascular resistance was reduced at the higher doses, the overall hemodynamic changes could not be distinguished from the normal autoregulatory response to changes in perfusion pressure. Within brain tissue, the regional effect of VIP may be dependent upon the presence or absence of the blood-brain barrier. Regions known to have low barrier permeability showed no response to VIP, whereas regions having high permeability, such as the pituitary, tended to show increases in flow. Speculation as to the significance of these findings is premature in view of the limited knowledge of factors controlling blood flow in the pituitary (Bergland and Page, 1979) . However, the results of several recent studies are pertinent to this discussion. VIP is present in substantial quantities in the hypothalamus (Besson et al., 1979; Emson et al., 1978; Larsson et al., 1976b; Samson et al., 1979) and hypophyseal portal blood (Said and Porter, 1978) . Within the pituitary, VIP is present in both the adenohypophysis and neurohypophysis . Although the role of VIP in pituitary function is uncertain, evidence suggests that it is somehow involved in the regulation and release of the pituitary hormones, prolactin (Kato et al., 1978) , growth hormone, and gonadotropin (Kato et al., 1978; Vijayan et al., 1979) .
Further consideration of problems with intra-arterial infusions of vasoactive substances in the dog is required. There are many anastomotic connections between intracranial and extracranial arterial systems; thus it is possible that during a slow intraarterial infusion, a laminar stream shunted VIP predominantly toward the extracranial vasculature. Therefore, VIP may not have reached the cerebral blood vessels in threshold concentrations. This alternative explanation for the lack of effect of VIP on cerebral vessels seems unlikely, since intra-arterial bolus injections of VIP also showed no effect.
The Effect of Intraventricular VIP
Various markers and solutes have been shown to pass into brain parenchyma when introduced into the CSF (Cserr, 1974; Patlak and Fenstermacher, 1975) . Brightman and Reese (1969) showed that the entry of peroxidase is predominantly through gap junctions that form connections between adjacent ependymal cell membranes and glia. Within the intercellular space, solute transfer occurs from the CSF to the perivascular space by both diffusion and bulk flow processes (Cserr, 1974) . Small molecules and ions may be lost from the tissue into the blood (Patlak and Fenstermacher, 1975) , whereas larger molecules, such as peroxidase, ferritin, and dextran, penetrate only as far as the endothelial cell membrane, where further diffusion is blocked by the tight junctions (Brightman and Reese, 1969; Cserr, 1974) .
Our studies show that VIP increases CBF when perfused into the CSF. Therefore, it may be assumed that a reasonable degree of penetration of VIP into the parenchyma occurred. However, in contrast to the marked increase in common carotid blood flow observed during intra-arterial VIP administration, smaller rCBF changes were seen during intraventricular VIP administration. These results suggest that cerebral vessels may be less sensitive to VIP than extracerebral vessels, as has been suggested for other pharmacological agents (Edvinsson and MacKenzie, 1977; O'Neill and Traystman, 1977) .
There are several alternate explanations why smaller responses were observed in the intracranial vasculature. First, the concentration of VIP within brain tissue is dependent upon multiple factors not considered in this study, such as the time required for VIP to establish steady state concentration in the ventricular system, the absolute CSF VIP concentration in the steady state, and the rate of movement of VIP into the extracellular fluid space from the CSF. Second, long-term intraventricular VIP perfusion appears to involve an escape phenomenon; that is, with sustained stimulation with VIP, rCBF was less after 60 minute perfusion than after 30-minute perfusion. The control group of animals prepared similarly and perfused over the same time period with mock CSF only, showed no change in rCBF. In VIP-perfused animals, arterial PCO2 was unchanged throughout the experiment and thus cannot account for the observed changes in rCBF. In the mesenteric circulation, escape has been shown to occur with VIP (Kachelhoffer et al., 1976) , as well as with norepinephrine and angiotensin II (Shehadeh et al., 1967) . In this respect, our rCBF values do not represent the maximum changes in blood flow that can be evoked with VIP at the 10-jiig/ml concentration. Finally, there are multiple peptidases and peptide reuptake mechanisms which are active on other peptides in the central nervous system (Marks, 1977) . The effect of these enzymes on VIP is unknown.
The Effect of Endogenous VIP on Cerebral Blood Flow
Several studies have suggested that the VlP-containing fibers of the gastrointestinal tract and brain maintain a sustained rate of VIP release and that this release can be modulated by stimuli that act through central or local reflexogenic mechanisms. In the gastrointestinal circulation, portal venous VIP concentration is higher than that of the mesenteric artery. Physiological stimulation such as mechanical distention of the esophagus, irritation of the duodenum and rectum, and stimulation of the vagus nerve can increase VIP release, whereas ganglionic blockade or sympathetic nerve stimulation attenuates the release (Fahrenkrug et al., 1978a (Fahrenkrug et al., , 1978b . In the central nervous system, VIP has been postulated to be a neurotransmitter (Besson et al., 1979; Fuxe et al., 1968; Larsson et al., 1976b; Said and Rosenberg, 1976) , but stimuli leading to the activation of central VIP neurons have yet to be identified. In this regard, Fahrenkrug et al. (1977) have shown that CSF VIP levels are higher than arterial VIP levels both in normal subjects and in patients with varying degrees of cerebral dysfunction. In the latter group, CSF VIP was not correlated with arterial VIP but was negatively correlated with the severity of the disorder, suggesting that CSF VIP is of neural origin rather than simply a consequence of diffusion from arterial plasma.
The significance of the VIP-containing nerve fibers that lie within the cerebral vessel wall is unknown. We hypothesized that a neurally evoked release of VIP during hypercapnia or hypoxia might be responsible for the cerebral vasodilation that occurs during these exposures. However, the results of our studies do not support this hypothesis. We were unable to show any change in VIP concentration of arterial or cerebral venous plasma, or in CSF during hypercapnia or hypoxia. Our results are consistent with those of Fahrenkrug et al. (1977) in that CSF VIP did not correlate significantly with arterial VIP. Although the mean arterial VIP concentration in our animals (123.4 ± 11.9 pg/ml) was higher than that reported by Fahrenkrug et al (1977) for normal human subjects (26.9 pg/ml), our values compare favorably with other control values obtained in human subjects using the same assay procedure (Said, 1979) and with previously reported values for anesthetized, surgically prepared animals (Sakio et al., 1979) .
The mean CSF VIP concentration in our animals (75.0 ± 8.7 pg/ml) was somewhat lower than that previously found in human subjects (183.3 pg/ml) (Fahrenkrug et al., 1977) , a finding that may be related to the effects of anesthesia. However, we were unable to provide support for this explanation since no correlation could be shown between cerebral oxygen consumption or cerebral venous VIP and CSF VIP concentration over the narrow range of metabolic states encountered in these animals. In our study, since cerebral venous VIP correlated well with, and was not significantly different from, arterial VIP, it would appear that there was no measurable quantity of VIP "spillover" from brain tissue into the cerebral venous effluent.
Our data are consistent with the hypothesis that the blood-brain barrier prevents VIP from penetrating into brain parenchyma from plasma. Since this barrier is not undirectional (Patlak and Fenstermacher, 1975 ), a reasonable explanation for our not showing significant VIP production during normocapnia, hypercapnia, or hypoxia using the arteriovenous difference method may be due to the impermeability of the barrier to VIP from the tissue rather than a negligable VIP release by VIP nerves. Alternatively, it may be argued that VIP is degraded rapidly at the release site or within the vessel wall. These explanations seem unlikely, however, because the active form of VIP entering from the arterial side of the vasculature passed essentially unaltered into the cerebral venous circulation. Neither hypercapnia nor hypoxia affected CSF VIP concentration; thus it would appear unlikely that VIP release could account for the remarkable increase in cerebral blood flow produced by these two conditions. The mode of action by which VIP increases rCBF is unclear. Besides the potent vasodilator properties of this peptide, VIP has a pronounced glycogenolytic effect on mammalian liver cells and can evoke lipolysis in mammalian fat cells (Desbuquois et al., 1973) . The increases in CBF produced by VIP therefore could be an indirect result of increases in metabolism within brain tissue as opposed to a direct vasodilation of cerebral vessels. Our data are consistent with the possibility that local release of VIP from perivascular nerve endings could affect CBF and thus may be involved in the neural regulation of the cerebral circulation. The unresponsiveness of cerebral vessels to blood-borne VIP may be due to the blood-brain barrier, since VIP dilates cerebral vessels when the barrier is bypassed by intraventricular infusion of VIP. These studies, however, do not support the hypothesis that CBF changes induced during hypercapnia or hypoxia are mediated by VIP.
